Grupo farmacéutico · Eslovenia
Krka
Un grupo de 21 empresas con 1845 medicamentos en 8 países.
Estructura del grupo
21 empresas en 8 países
Cargando…
Grupo farmacéutico · Eslovenia
Un grupo de 21 empresas con 1845 medicamentos en 8 países.
21 empresas en 8 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 1845
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| Abidalo 2,5 mg filmom obložene tableteFilmom obložena tableta | Apixaban | Croacia | No comercializado | 2026 |
| Abidalo 5 mg filmom obložene tableteFilmom obložena tableta | Apixaban | Croacia | No comercializado | 2026 |
| Abirateron Krka500mg · film tableta | Abiraterone | Serbia | Autorizado | 2022 |
| Abirateron Krka500mg · film tableta | Abiraterone | Serbia | Autorizado | 2022 |
| Abirateron Krka500mg · film tableta | Abiraterone | Serbia | Autorizado | 2022 |
| Abirateron Krka500mg · film tableta | Abiraterone | Serbia | Autorizado | 2022 |
| ABIRATERONA KRKA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg · Comprimido recubierto con película | Abiraterone | España | Comercializado | 2021 |
| Abiraterone Krka | Abiraterone | UE (EMA) | Autorizado | 2021 |
| Abiraterone Krka 500 mg, filmomhulde tablettenFilmomhulde tablet | Abiraterone | Países Bajos | Autorizado | 2021 |
| Aboxoma5mg · film tableta | Apixaban | Serbia | Autorizado | 2022 |
| Aboxoma2.5mg · film tableta | Apixaban | Serbia | Autorizado | 2022 |
| Aboxoma2.5mg · film tableta | Apixaban | Serbia | Autorizado | 2022 |
| Aboxoma 2,5 mg filmom obložene tableteFilmom obložena tableta | Apixaban | Croacia | No comercializado | 2026 |
| Aboxoma 5 mg filmom obložene tableteFilmom obložena tableta | Apixaban | Croacia | No comercializado | 2026 |
| ACIDO ACETILSALICILICO KRKA 100 MG COMPRIMIDOS GASTRORRESISTENTES100 mg · Comprimido gastrorresistente | Acetylsalicylic acid | España | Comercializado | 2017 |
| Aclexa 100 mg tvrde kapsulekapsula, tvrda | Celecoxib | Croacia | Comercializado | 2019 |
| Aclexa 200 mg tvrde kapsulekapsula, tvrda | Celecoxib | Croacia | Comercializado | 2019 |
| Adolax 10 mg/5 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Oxycodone, Naloxone | Croacia | Comercializado | 2021 |
| Adolax 20 mg/10 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Oxycodone, Naloxone | Croacia | Comercializado | 2021 |
| Adolax 40 mg/20 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Oxycodone, Naloxone | Croacia | Comercializado | 2021 |
| Agomaval 25 mg, filmomhulde tablettenFilmomhulde tablet | Agomelatine | Países Bajos | Autorizado | 2018 |
| ALPRAZOLAM KRKA 0.25 MG COMPRIMIDOS EFG0.250 mg · Comprimido | Alprazolam | España | Comercializado | 2018 |
| Alprazolam Krka 0,25 mg tabletetableta | Alprazolam | Croacia | No comercializado | 2022 |
| ALPRAZOLAM KRKA 0.5 MG COMPRIMIDOS EFG0.500 mg · Comprimido | Alprazolam | España | Comercializado | 2018 |
| Alprazolam Krka 0,5 mg tabletetableta | Alprazolam | Croacia | No comercializado | 2022 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Croacia | 493 | 493 | 0 | EmpresasTodos los medicamentos |
| España | 460 | 400 | 60 | EmpresasTodos los medicamentos |
| Serbia | 434 | 424 | 10 | EmpresasTodos los medicamentos |
| Países Bajos | 231 | 231 | 0 | EmpresasTodos los medicamentos |
| Rumanía | 187 | 0 | 187 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 31 | 24 | 7 | EmpresasTodos los medicamentos |
| Arabia Saudí | 8 | 8 | 0 | EmpresasTodos los medicamentos |
| Italia | 1 | 1 | 0 | EmpresasTodos los medicamentos |
También en los registros de Estados Unidos, Francia, Malasia, Reino Unido, Singapur, Suecia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licencia: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Krka en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.